Susanne Schinke

Luebeck, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Advancing research on regulatory autoantibodies targeting GPCRs: Insights from the 5th international symposium.

Advancing research on regulatory autoantibodies targeting GPCRs: Insights from the 5th international symposium.

Journal: Autoimmunity reviews

Published: April 11, 2025

Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases.

Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases.

Journal: RMD open

Published: January 25, 2025

Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung disease.

Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung disease.

Journal: Respiratory medicine

Published: January 18, 2024

B symptoms in unexplained mediastinal lymphadenopathy : Case report of a 72-year-old male patient with VEXAS syndrome

B symptoms in unexplained mediastinal lymphadenopathy : Case report of a 72-year-old male patient with VEXAS syndrome

Journal: Innere Medizin (Heidelberg, Germany)

Published: May 12, 2023

Therapy satisfaction and health literacy are key factors to improve medication adherence in systemic sclerosis.

Therapy satisfaction and health literacy are key factors to improve medication adherence in systemic sclerosis.

Journal: Scandinavian journal of rheumatology

Published: September 20, 2022

Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.

Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.

Journal: ERJ open research

Published: August 01, 2022

Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 11, 2022

The unusual mimicker of a polymyositis

The unusual mimicker of a polymyositis

Journal: Zeitschrift fur Rheumatologie

Published: February 01, 2022

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis.

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis.

Journal: Rheumatology advances in practice

Published: March 16, 2021

Systemic sclerosis

Systemic sclerosis

Journal: Der Internist

Published: November 23, 2019

Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis.

Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis.

Journal: Annals of the rheumatic diseases

Published: March 06, 2019

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis.

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis.

Journal: Nature communications

Published: May 21, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026